Protective role of caffeic acid phenethyl ester and erdosteine on activities of purine-catabolizing enzymes and level of nitric oxide in red blood cells of isoniazid-administered rats*
Restricted accessResearch articleFirst published online September, 2008
Protective role of caffeic acid phenethyl ester and erdosteine on activities of purine-catabolizing enzymes and level of nitric oxide in red blood cells of isoniazid-administered rats*
The aim of this experimental study was to investigate the possible role of nitric oxide (NO) and the activities of adenosine deaminase (ADA) and xanthine oxidase (XO) in the pathogenesis of isoniazid (INH)-induced oxidative damage in red blood cells (RBCs), and also to show the effect of caffeic acid phenethyl ester (CAPE) and erdosteine, antioxidants, in decreasing this toxicity. A total of 25 adult male rats were divided into four experimental groups as follows: control group (n = 7), INH-treated group (n = 6), INH + CAPE–treated group (n = 6), and INH + erdosteine–treated group (n = 6). INH, INH-CAPE, and INH-erdosteine–treated groups were treated orally with INH 50 mg/kg daily and with the tap water for 15 days. Control group was given only tap water. CAPE was intraperitoneally injected for 15 days at a dose of 10 μmol/kg. Erdosteine was treated orally for 15 days at a dose of 10 mg/kg/day. The injection of INH led to a significant increase in the activities of ADA, XO, and NO levels in RBCs of rats. Co-treatment with CAPE caused a significant decrease in the activities of ADA and XO and the levels of NO in RBCs. In addition, co-treatment with erdosteine caused a significant decrease in the activities of ADA and XO and the levels of NO in RBCs. The results of this study showed that ADA, XO, and NO may play an important role in the pathogenesis of INH-induced oxidative stress in RBCs. CAPE and erdosteine may have protective potential in this process and they may become a promising drug in the prevention of this undesired side effect of INH.
Amacher DE Schomaker SJ (1998) Ethylmorphine N-demethylase activity as a marker for cytochrome P450 CYP3A activity in rat hepatic microsomes. Toxicol Lett94: 115–125.
2.
Andrzheiuk NI Smirnova NA Narovlianskaia SE Novoselova VP Kruglova EG (1990) The pro-fibrotic and pro-oxidant action of isoniazid. Probl Tuberk8: 7–11.
3.
Attri S Rana SV Vaiphei K Sodhi CP Katyal R Goel RC (2000) Isoniazid- and rifampicin-induced oxidative hepatic injury–protection by N-acetylcysteine. Hum Exp Toxicol19: 517–522.
4.
Balli F Bergamini B Calistru P Ciofu EP Domenici R Doros G (2007) Clinical effects of erdosteine in the treatment of acute respiratory tract diseases in children. Int J Clin Pharmacol Ther45: 16–22.
5.
Banerjee T Kuypers FA (2004) Reactive oxygen species and phosphatidylserine externalization in murine sickle red cells. Br J Haematol124: 391–402.
6.
Bor-Kucukatay M Yalcin O Gokalp O Kipmen-Korgun D Yesilkaya A Baykal A (2000) Red blood cell rheological alterations in hypertension induced by chronic inhibition of nitric oxide synthesis in rats. Clin Hemorheol Microcirc22: 267–275.
7.
Braga PC Dal Sasso MD Zuccotti T (2000) Assessment of the antioxidant activity of the SH metabolite I of erdosteine on human neutrophil oxidative bursts. Arzneimittelforschung50: 739–746.
8.
Chen YJ Shiao MS Wang SY (2001) The antioxidant caffeic acid phenethyl ester induces apoptosis associated with selective scavenging of hydrogen peroxide in human leukemic HL-60 cells. Anticancer Drugs12: 143–149.
9.
Cicek E Sutcu R Gokalp O Yilmaz HR Ozer MK Uz E (2005) The effects of isoniazid on hippocampal NMDA receptors: protective role of erdosteine. Mol Cell Biochem277: 131–135.
10.
Cortas NK Wakid NW (1990) Determination of inorganic nitrate in serum and ürine by a kinetic cadmium-reduction method. Clin Chem36: 1440–1443.
11.
Dacie JV Lewis SM (1984) Practical Haematology.New York: Churchill Livingstone, pp. 32.
12.
Dechant KL Noble S (1996) Erdosteine. Drugs52: 875–881.
13.
Erdogan H Fadillioglu E Yagmurca M Ucar M Irmak MK (2006) Protein oxidation and lipid peroxidation after renal ischemia-reperfusion injury: protective effects of erdosteine and N-acetylcysteine. Urol Res34: 41–46.
14.
Fadillioglu E Yilmaz HR Erdogan H Sogut S (2003) The activities of tissue xanthine oxidase and adenosine deaminase and the levels of hydroxyproline and nitric oxide in rat hearts subjected to doxorubicin: protective effect of erdosteine. Toxicology191: 153–158.
15.
Fesen MR Pommier Y Leteurtre F Hiroguchi S Yung J Kohn KW (1994) Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compounds. Biochem Pharmacol48: 595–608.
16.
Gazzani G Fregnan GB Vandoni G (1989) In vitro protection by erdosteine against oxidative inactivation of alpha-1-antitrypsin by cigarette smoke. Respiration55: 113–118.
17.
Gebhart E Kysela D Matthee H Nikol M (1985) Cytogenetic analyses utilizing various clastogens in two sibs with Fanconi anemia, their relatives, and control individuals. Hum Genet69: 309–315.
18.
Giusti G (1974) Adenosine deaminase. In: MV Bergmeyer (ed), Methods of Enzymatic Analysis, second ed.New York: Academic Press, pp. 1092–1098.
19.
Gokalp O Uz E Cicek E Yilmaz HR Ozer MK Altunbasak A (2006) Ameliorating role of caffeic acid phenethyl ester (CAPE) against isoniazid-induced oxidative damage in red blood cells. Mol Cell Biochem290: 55–59.
20.
Ince H Kandemir E Bagci C Gulec M Akyol O (2006) The effect of caffeic acid phenethyl ester on short-term acute myocardial ischemia. Med Sci Monit12: BR187–BR193.
21.
Jones HB Cavanagh JB (1981) Comparison between the early changes in isoniazid intoxication and the chromatolytic response to nerve ligation in spinal ganglion cells of the rat. Neuropathol Appl Neurobiol7: 489–501.
22.
Kalcioglu MT Kizilay A Yilmaz HR Uz E Gulec M Ozturan O (2004) Adenosine deaminase, xanthine oxidase, superoxide dismutase, glutathione peroxidase activities and malondialdehyde levels in the sera of patients with head and neck carcinoma. Kulak Burun Boğaz İhtis Derg12: 16–22.
23.
Koltuksuz U Mutuş HM Kutlu R Ozyurt H Cetin S Karaman A (2001) Effects of caffeic acid phenethyl ester and epidermal growth factor on the development of caustic esophageal stricture in rats. J Pediatr Surg36: 1504–1509.
24.
Lewis CR Manoharan A (1987) Pure red cell hypoplasia secondary to isoniazid. Postgrad Med J63: 309–310.
25.
Michaluart P Masferrer JL Carothers AM Subbaramaiah K Zweifel BS Koboldt C (1999) Inhibitory effects of caffeic acid phenethyl ester on the activity and expression of cyclooxygenase-2 in human oral epithelial cells and in a rat model of inflammation. Cancer Res59: 2347–2352.
26.
National Institutes of Health Guide for the Care and Use of Laboratory Animals, DHEW Publication No. (NIH) 85–23, Revised (1985) Office of Science and Health Reports. Bethesda, USA: DRR/NIH.
27.
Park JH Lee JK Kim HS Chung ST Eom JH Kim KA (2004) Immunomodulatory effect of caffeic acid phenethyl ester in Balb/c mice. Int Immunopharmacol4: 429–436.
28.
Prajda N Weber G (1975) Malignant transformation-linked imbalance: decreased XO activity in hepatomas. FEBS Lett59: 245–249.
29.
Rubbo H O'Donnell V (2005) Nitric oxide, peroxynitrite and lipoxygenase in atherogenesis: mechanistic insights. Toxicology208: 305–317.
30.
Sahin M Cam H Olgar S Tunc SE Arslan C Uz E (2006) Protective role of erdosteine on vancomycin-induced oxidative stress in rat liver. Mol Cell Biochem291: 155–160.
31.
Shah BR Santucci K Sinert R Steiner P (1995) Acute isoniazid neurotoxicity in an urban hospital. Pediatrics95: 700–704.
32.
Sodhi CP Rana SV Mehta SK Vaiphei K Attri S Thakur S (1996) Study of oxidative stress in isoniazid-induced hepatic injury in young rats with and without protein-energy malnutrition. J Biochem Toxicol11: 139–146.
33.
Sogut S Kotuk M Yilmaz HR Ulu R Ozyurt H Yildirim Z (2004) In vivo evidence suggesting a role for purine-catabolizing enzymes in the pathogenesis of cisplatin-induced nephrotoxicity in rats and effect of erdosteine against this toxicity. Cell Biochem Funct22: 157–162.
34.
Sud’ina GF Mirzoeva OK Pushkareva MA Korshunova GA Sumbatyan NV Varfolomeev SD (1993) Caffeic acid phenethyl ester as a lipoxygenase inhibitor with antioxidant properties. FEBS Lett329: 21–24.
35.
Thomas BH Whitehouse LW Zeitz W (1984) Metabolism of [14C]acetylisoniazid and [14C]acetylhydrazine by the rat and rabbit. Fundam Appl Toxicol4: 646–653.
36.
Uz E Oktem F Yilmaz HR Uzar E Ozgüner F (2005) The activities of purine-catabolizing enzymes and the level of nitric oxide in rat kidneys subjected to methotrexate: protective effect of caffeic acid phenethyl ester. Mol Cell Biochem277: 165–170.
37.
Uzar E Sahin O Koyuncuoglu HR Uz E Bas O Kilbas S (2006) The activity of adenosine deaminase and the level of nitric oxide in spinal cord of methotrexate administered rats: protective effect of caffeic acid phenethyl ester. Toxicology218: 125–133.
38.
Yilmaz HR Iraz M Sogut S Ozyurt H Yildirim Z Akyol O (2004a) The effects of erdosteine on the activities of some metabolic enzymes during cisplatin-induced nephrotoxicity in rats. Pharmacol Res50: 287–290.
39.
Yilmaz HR Uz E Yucel N Altuntas I Ozcelik N (2004b) Protective effect of caffeic acid phenethyl ester (CAPE) on lipid peroxidation and antioxidant enzymes in diabetic rat liver. J Biochem Mol Toxicol18: 234–238.
40.
Yilmaz HR Sogut S Ozyurt B Ozugurlu F Sahin S Isik B (2005) The activities of liver adenosine deaminase, xanthine oxidase, catalase, superoxide dismutase enzymes and the levels of malondialdehyde and nitric oxide after cisplatin toxicity in rats: protective effect of caffeic acid phenethyl ester. Toxicol Ind Health21: 67–73.
41.
Yoshimoto S Takeuchi M Tada A (1992) Secondary sideroblastic anemia caused by long term administration of anti-tuberculous agents including isoniazid. Rinshō Ketsueki33: 986–990.
